Bulk Pharmaceutical API Sources for MICROGESTIN 1.5/30

Bulk Pharmaceutical API Sources for MICROGESTIN 1.5/30

Vendor	Vendor Homepage	Vendor Sku	API Url
ABI Chem		AC1L1Y7Y
BenchChem		B1214198
THE BioTek		bt-1551125
RR Scientific		R5164299

Last updated: August 5, 2025

lk Active Pharmaceutical Ingredient (API) Sources for: MICROGESTIN 1.5/30

Introduction
Microgestin 1.5/30 is a combined oral contraceptive pill consisting of ethinylestradiol (1.5 mg) and desogestrel (0.03 mg). As with all pharmaceutical products, the efficacy and safety of Microgestin 1.5/30 fundamentally depend on the quality of its active pharmaceutical ingredients (APIs). The sourcing of high-quality, compliant APIs is vital for pharmaceutical manufacturers aiming to meet regulatory standards, ensure product safety, and maintain consistent supply chains. This analysis delineates potential API sources for ethinylestradiol and desogestrel, identifies key market players, and discusses considerations when selecting API suppliers.

Regulatory Framework and Quality Standards
APIs must adhere to stringent regulatory requirements, including those set by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other global agencies. International standards such as the Current Good Manufacturing Practices (cGMP) dictate quality, purity, and consistency. API suppliers must provide comprehensive documentation, including Certificates of Analysis (CoA), stability data, and compliance certifications.

Ethinylestradiol (EE) API Sources

1. Major Manufacturers and Suppliers
The global market for ethinylestradiol is primarily dominated by large, integrated pharmaceutical ingredient manufacturers. Key suppliers include:

• Zhejiang Medicine Co., Ltd. (China)
  Zhejiang Medicine is a prominent API producer, offering high-grade ethinylestradiol with documented cGMP compliance. Their facilities are certified by regulatory bodies, and they supply APIs globally, including to North America and Europe.

• Mingfeng Pharmaceutical (China)
  Mingfeng provides ethynylestradiol with consistent purity levels, approved for use in finished drug products marketed internationally. The company maintains rigorous quality control measures aligned with international standards.

• Swanbio Pharmaceutical (India)
  A notable provider of estrogenic APIs, Swanbio offers ethinylestradiol produced under cGMP conditions with extensive regulatory dossier support.

• LGM Pharma (USA)
  LGM Pharma supplies a variety of hormones, including ethynylestradiol, sourced from multiple approved manufacturers, ensuring supply chain flexibility and compliance.

• Qingdao Yousuo Pharmaceutical Co., Ltd. (China)
  Specializes in steroid hormone APIs, including ethinylestradiol, with approvals from global regulatory authorities.

2. Sourcing Considerations

• Regulatory Compliance: Suppliers must hold cGMP certification recognized by relevant authorities.
• Quality Certifications: ISO certifications, and strict QA/QC protocols are essential to ensure API purity and stability.
• Supply Capacity: Manufacturers with demonstrated capacity to meet large or ongoing orders are preferable to avoid supply disruptions.
• Documentation and Dossier Support: Suppliers should provide comprehensive analytical data, stability studies, and manufacturing process details suitable for regulatory submissions.

Desogestrel API Sources

1. Market Leaders and Producers
Desogestrel, a progestin used in contraceptives like Microgestin 1.5/30, is produced predominantly by specialized API manufacturers:

• Ferring Pharmaceuticals (Sweden)
  A pioneer in progestin manufacturing, Ferring offers desogestrel APIs with high purity and cGMP compliance, serving global markets.

• Songwon Chemical Co., Ltd. (South Korea)
  Provides desogestrel APIs with validated manufacturing processes, adhering to international quality standards.

• Mingfeng Pharmaceutical (China)
  Also supplies desogestrel with verified stability and purity levels as part of their steroid hormone portfolio.

• LGM Pharma (USA)
  Sources desogestrel from qualified manufacturers, offering regulatory support and documentation.

• VHB Life Sciences (India)
  Offers desogestrel API, complying with cGMP, with a focus on the regulatory documentation necessary for global drug approval processes.

2. Selection Criteria for Desogestrel API Suppliers

• Regulatory Status: Suppliers with FDA and EMA approvals facilitate smoother incorporation into finished pharmaceutical products.
• Certifications and Quality Control: Strict adherence to cGMP, ISO standards, and batch-to-batch consistency are mandatory.
• Pricing and Lead Time: Competitive pricing coupled with reliable delivery schedules are critical considerations.

Global API Market Dynamics and Challenges

While multiple suppliers provide ethynylestradiol and desogestrel, recent trends involve an emphasis on supply chain resilience amidst geopolitical tensions, Covid-19 disruptions, and regulatory scrutiny. Sourcing from multiple suppliers, including both domestic and international manufacturers, helps mitigate risks related to quality, supply continuity, and cost fluctuations.

Evaluating API Suppliers

Pharmaceutical companies seeking API sources for Microgestin 1.5/30 should undertake comprehensive due diligence, analyzing:

• Regulatory compliance and documentation integrity.
• Production capacity and quality assurance processes.
• Historical reliability and reputation in the industry.
• Pricing structures and contractual flexibility.
• Supply chain transparency and lead times.

Emerging Trends

Growing regulatory demands for traceability and the shift toward sourcing APIs from countries with rigorous quality standards are reshaping procurement strategies. Additionally, advances in synthetic processes and green chemistry are influencing the selection of suppliers capable of implementing sustainable manufacturing practices.

Conclusion

The API market for ethinylestradiol and desogestrel, the active components in Microgestin 1.5/30, is globally distributed, with prominent players in China, India, South Korea, and Europe. Ensuring supply chain robustness involves rigorous supplier evaluation based on regulatory certifications, manufacturing quality, capacity, and compliance documentation. As demand for oral contraceptives continues to grow, establishing reliable relationships with certified API manufacturers remains essential to maintaining product quality and regulatory approval.

---

Key Takeaways

• Diverse sourcing: Rely on multiple certified API suppliers to mitigate risks and ensure uninterrupted supply.
• Regulatory compliance: Prioritize suppliers with cGMP certification, comprehensive documentation, and proven regulatory track records.
• Quality assurance: Conduct thorough audits and quality control assessments before onboarding new API vendors.
• Cost and capacity considerations: Balance competitive pricing with manufacturing capacity and lead times to meet market demands.
• Emerging trends: Monitor developments in sustainable manufacturing and geopolitical factors affecting API sourcing strategies.

---

FAQs

1. What are the primary geographic regions for sourcing APIs for Microgestin 1.5/30?
Major API manufacturing hubs include China, India, South Korea, and Europe, each offering high-quality products compliant with international standards.

2. How can manufacturers verify the quality of API suppliers?
By reviewing certifications such as cGMP, ISO, and inspecting manufacturing facilities, along with analyzing Certificates of Analysis and regulatory documentation.

3. What are the key considerations when choosing an API supplier for contraceptives?
Regulatory compliance, quality control, production capacity, supply reliability, and pricing structure.

4. How does geopolitical and supply chain stability impact API sourcing?
Disruptions due to geopolitical tensions or pandemics can delay supply; diversification and supplier audits help mitigate these risks.

5. Are there any emerging markets or suppliers gaining prominence in API manufacturing?
Yes, countries like Bangladesh, Vietnam, and Mexico are increasingly becoming notable for API manufacturing, driven by cost advantages and expanding regulatory capabilities.

---

Sources
[1] European Pharmacopoeia. EP Standards for APIs.
[2] FDA Guidance for Industry: Quality Considerations in Demonstrating Compliance with cGMP.
[3] Global Industry Reports. API Market Overview.
[4] Manufacturer websites and regulatory submissions from Zhejiang Medicine, Mingfeng Pharmaceutical, Ferring Pharmaceuticals, and others.